Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery-Reference-Cited by-同舟云学术

Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery

Published:2018-01 Issue:1 Volume:163 Page:191-196
ISSN:0039-6060
Container-title:Surgery
language:en
Short-container-title:Surgery

Author:

Nockel Pavel,El Lakis Mustapha,Gaitanidis Apostolos^ORCID,Yang Lily,Merkel Roxanne,Patel Dhaval,Nilubol Naris,Prodanov Tamara,Pacak Karel,Kebebew Electron

Publisher

Elsevier BV

Subject

Surgery

Reference16 articles.

1. Phaeochromocytoma;Lenders;Lancet (London, England),2005

2. Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines?;Stolk;J Clin Endocrinol Metab,2013

3. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients;Curras-Freixes;Journal Med Genet,2015

4. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors;Babic;Surgery,2017

5. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline;Lenders;J Clin Endocrinol Metab,2014

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Review: The Approach to the Evaluation and Management of Bilateral Adrenal Masses;Endocrine Practice;2024-08

2. Challenges in genetic screening for inherited endocrinopathy affecting the thyroid, parathyroid and adrenal glands in Singapore;Annals of the Academy of Medicine, Singapore;2024-04-29

3. Tumor metabolism in pheochromocytomas: clinical and therapeutic implications;Exploration of Targeted Anti-tumor Therapy;2024-04-24

4. The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives;Pharmaceuticals;2024-03-08

5. Development and internal validation of a novel predictive model for SDHB mutations in pheochromocytomas and retroperitoneal paragangliomas;Frontiers in Endocrinology;2023-12-21